96. クローン病 [臨床試験数:2,209,薬物数:1,276(DrugBank:240),標的遺伝子数:166,標的パスウェイ数:210

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
7 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04186247December 20202/12/2019Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD)Personalized AZithromycin/metronidAZole, in Combination With Standard Induction Therapy, to Achieve a Fecal Microbiome Community Structure and Metagenome Changes Associated With Sustained Remission in Pediatric Crohn's Disease (CD): a Pilot StudyCrohn Disease;Pediatric Crohns DiseaseDrug: Azithromycin;Drug: Metronidazole;Other: Standard of CareUniversity of North Carolina, Chapel HillCrohn's and Colitis Foundation;University of AmsterdamNot yet recruiting3 Years17 YearsAll20Phase 2United States;Canada;Israel;Netherlands
2EUCTR2019-004219-29-NL21/04/202004/02/2020Personalized antibiotic therapy in combination with standard therapy to achieve a fecal profile associated with prolonged complaint-free period in pediatric Crohn’s DiseasePersonalized AZithromycin/metronidAZole, in combination with standard induction therapy, to achieve a fecal microbiome community structure and metagenome changes associated with sustained remission in pediatric Crohn’s Disease (CD): a pilot study” - PAZAZ Crohn's Disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Trade Name: Azithromycin
Product Name: Azithromycin
INN or Proposed INN: Azithromycin
Other descriptive name: AZITHROMYCIN
Trade Name: Metronidazole
Product Name: Metronidazole
INN or Proposed INN: METRONIDAZOLE
Other descriptive name: METRONIDAZOLE
Amsterdam UMCNULLNot RecruitingFemale: yes
Male: yes
20Phase 2United States;Canada;Israel;Netherlands
3EUCTR2012-005226-29-PL16/01/201419/09/2013Antibiotic therapy for children with active Crohn's diseaseAzithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease - AZCRO Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Product Name: azithromycin
Trade Name: metronidazole
Product Name: metronidazole
Product Name: azithromycin
Product Name: azithromycin
Erasmus MCHospital S. Joao;University hospital Brussel;Jagiellonian University Medical CollegeNot RecruitingFemale: yes
Male: yes
70Portugal;United States;Canada;Belgium;Poland;Israel;Netherlands
4EUCTR2012-005226-29-PT20/12/201324/09/2013Antibiotic therapy for children with active Crohn's diseaseAzithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease - AZCRO Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Product Name: azithromycin
INN or Proposed INN: azithromycin
Other descriptive name: AZITHROMYCIN
Trade Name: metronidazole
Product Name: metronidazole
INN or Proposed INN: METRONIDAZOLE
Other descriptive name: Metronidazole
Centro Hospitalar de São João E.P.E.NULLNot RecruitingFemale: yes
Male: yes
70Phase 3United States;Portugal;Canada;Poland;Belgium;Israel;Netherlands
5EUCTR2012-005226-29-BE26/04/201314/03/2013Antibiotic therapy for children with active Crohn's diseaseAzithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease - AZCRO Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Product Name: azithromycin
Trade Name: metronidazole
Product Name: metronidazole
Wolfson Medical CenterNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
70Portugal;United States;Canada;Poland;Belgium;Israel;Netherlands
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
6NCT01596894October 201212/4/2012Azithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's DiseaseA Randomized, Single Blinded, Controlled, Multi Center Phase 4 Study for Induction of Remission in Active Pediatric Crohn's Disease, Using 2 Months Antibiotic Course of Azithromycin Combined With Metronidazole vs. Metronidazole Alone.Crohn's DiseaseDrug: Azithromycin + Metronidazole;Drug: MetronidazoleProf. Arie LevineNULLCompleted5 Years17 YearsAll73Phase 4Israel
7EUCTR2012-005226-29-NL08/03/2013Antibiotic therapy for children with active Crohn's diseaseAzithromycin Based Therapy for Induction of Remission in Active Pediatric Crohn's Disease - AZCRO Crohn's disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]Product Name: azithromycin
Trade Name: metronidazole
Product Name: metronidazole
Wolfson Medical CenterNULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
70United States;Canada;Israel;Netherlands